(Q38812202)

6 September 2017

The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo (English)

1 reference

6 September 2017

1 reference

1 reference

Wan-Yu Li

1

1 reference

6 September 2017

Ji-Hua Ren

2

1 reference

6 September 2017

Na-Na Tao

3

1 reference

6 September 2017

Long-Kuan Ran

4

1 reference

6 September 2017

Xiang Chen

5

1 reference

6 September 2017

Hong-Zhong Zhou

6

1 reference

6 September 2017

Bo Liu

7

1 reference

6 September 2017

Xiao-Song Li

8

1 reference

6 September 2017

Ai-Long Huang

9

1 reference

6 September 2017

Juan Chen

10

1 reference

6 September 2017

12 December 2015

1 reference

6 September 2017

1 reference

6 September 2017

161

1 reference

6 September 2017

3

1 reference

6 September 2017

621-630

1 reference

https://scigraph.springernature.com/pub.10.1007/s00705-015-2712-8

6 September 2017

0 references

cites work

Therapeutic window for nicotinamide following transient focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

The new life of a centenarian: signalling functions of NAD(P).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Inhibition of vaccinia virus replication by nicotinamide: evidence for ADP-ribosylation of viral proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Vitamin B3 and sirtuin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Possible role of ADP-ribosylation of adenovirus core proteins in virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

21 January 2018

Use of Niacin as a Drug

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Hepatitis B virus infection--natural history and clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Medical virology of hepatitis B: how it began and where we are now

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Nicotinamide reduces acute cortical neuronal death and edema in the traumatically injured brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Mechanism of Nicotinamide Inhibition and Transglycosidation by Sir2 Histone/Protein Deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Nicotinamide: A Nutritional Supplement that Provides Protection Against Neuronal and Vascular Injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Novel directions for diabetes mellitus drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Sirtuins in mammals: insights into their biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Hepatitis B virus X protein: a multifunctional viral regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Nicotinamide inhibits HIV-1 in both acute and chronic in vitro infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Control of hepatitis B virus at the level of transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Sirtuin 1 regulates hepatitis B virus transcription and replication by targeting transcription factor AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Hepatitis B virus biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Poly(ADP-ribose) polymerase inhibitors suppress UV-induced human immunodeficiency virus type 1 gene expression at the posttranscriptional level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

SIRT2 regulates ciliogenesis and contributes to abnormal centrosome amplification caused by loss of polycystin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

Hepatitis B: reflections on the current approach to antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-015-2712-8

10.1007/S00705-015-2712-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference